Dengue fever

Showing 7 posts of 7 posts found.

takeda_usa_pharmaceuticals_u

Takeda’s dengue vaccine proves efficacious in massive Phase 3 trial

January 30, 2019
Research and Development Dengue fever, TAK-003, Takeda, Vaccine, dengue, health, infectious diseases

Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …

msd

MSD announced collaboration with Brazilian non-profit over development of dengue vaccine

December 13, 2018
Business Services, Medical Communications, Research and Development Dengue fever, HPV, hepatitis a, vaccines, virus

US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing …

Sun Pharma to partner with ICGEB to develop novel Dengue treatment

May 4, 2016
Research and Development Dengue fever, Sun Pharma, collaboration, dengue, development, drug, icgeb, international centre for genetic engineering and biotechnology, partnership, sun pharmaceutical

Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …

Sanofi image

Setback for Sanofi dengue vaccine

September 13, 2012
Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine

Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …

Sanofi partners on dengue vaccine awareness

February 22, 2011
Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines

Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …

mosquito

Medivir and Janssen in dengue fever research alliance

February 14, 2011
Research and Development Dengue fever, Medivir

Medivir, the speciality pharma company focused on infectious diseases, it to collaborate with Janssen on discovering and developing new medicines …

Sanofi refocuses its French manufacturing capacity

April 1, 2010
Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics

Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …

Latest content